The competitiveness of China’s biopharmaceutical industry is an approach to measure the capability of biopharmaceutical products, the capability of occupying the international market shares and the ability to obtain profits. It is the most important to analyze the competitiveness of biopharmaceutical filed in order to clearly confirm the position of international division and develop appropriate industrial policy. In this paper, four key elements and two factors were created as the analysis frame according to the characteristics of the biopharmaceutical industry with the porter diamond model. Six factor can affect the competitiveness of China’s biopharmaceutical filed, i.e. the production elements, requirements elements, relevant and supportive elements, corporations’ strategic architecture elements, government factor and competitive factor. In conclusion, biopharmaceutical industry in China is in translation stage from investment-driven to innovation-driven.